IP Verse

Strawman competitive analysis

Explore patent oppositions filed by Strawman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 22, 2026

Patent Number	Title	Applicant	Opposition Date
EP4335929	Non-Invasive Determination Of Methylome Of Tumor From Plasma	THE CHINESE UNIVERSITY OF HONG KONG	Oct 21, 2026
EP3083933	Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product Quality	BIOGEN MA	Oct 20, 2026
EP3434767	Cytotoxicity-Inducing Therapeutic Agent	CHUGAI SEIYAKU KABUSHIKI KAISHA	Sep 29, 2026
EP4458350	Lipid Nanoparticle Compositions And Methods For Mrna Delivery	TRANSLATE BIO	Sep 24, 2026
EP3974180	Method For Producing A Thermoformed And Press-Hardened Steel Sheet Component	VOLKSWAGEN	Sep 18, 2026
EP3783027	Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases	OSE IMMUNOTHERAPEUTICS	Sep 3, 2026
EP3672684	Electroporation Delivery Systems And Methods Of Using Electroporation Delivery Systems	CARDIAC PACEMAKERS	Sep 2, 2026
EP4025192	Process For Producing A Tablet Comprising Glp-1 Peptides	NOVO NORDISK	Sep 2, 2026
EP3449940	Antibody-Containing Preparation	CHUGAI SEIYAKU KABUSHIKI KAISHA	Aug 18, 2026
EP3310340	High Concentration Formulation	CASSIOPEA	Aug 5, 2026

Discover the latest PTAB cases involving Strawman, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Strawman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 22, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
STRAWMAN	476	-	-	-
AMGEN	14	164	8	11
CHUGAI SEIYAKU KABUSHIKI KAISHA	4	115	-	1
NOVARTIS	12	546	-	21